Serum complements C3 and C4 in chronic HCV infection and their correlation with response to pegylated interferon and ribavirin treatment.

作者: Abd El- Fatah Fahmy Hanno , Khaled Mahmoud Mohiedeen , Akram Deghedy , Reeham Sayed

DOI: 10.1016/J.AJG.2014.04.005

关键词:

摘要: Abstract Background and study aims To search for an immunological parameter that may correlate with the response to interferon (IFN) treatment is very crucial. The objective of this was levels C3 C4 complement components IFN in patients chronic hepatitis C virus (HCV) infection. Patients methods This conducted on 100 control subjects classified into three groups. Group (I) consisted 50 who were receiving showed various responses; group (II) included 25 naive treatment; (III) healthy matched age sex served as controls. Measurement level done by a quantitative turbidimetric test. at end 48th week. Results Serum found be significantly reduced all HCV infection both groups (I II) compared ( p p  = 0.025 0.05, respectively). There significant negative correlation between concentration serum alanine aminotransferase (ALT) measured simultaneously. Conclusion Higher concentrations positively correlated end-of-treatment treated ribavirin.

参考文章(22)
Mohammad Vasei, Monabbati A, Mahvash Alizadeh-Naeeni, Soodabeh Houshmand, Negar Azarpira, Kamran Bagheri Lankarani, Mahnaz Mosallaee, Taghavi Sa, Bita Geramizadeh, Mehdi Saberi-Firouzi, Mohammad Hadi Imaniyeh, Immunoglobulin and complement depositions in the liver of chronic hepatitis patients. Hepato-gastroenterology. ,vol. 55, pp. 1066- 1070 ,(2008)
OS Ali, Maha A Abo-Shadi, Lamiaa N Hammad, The biological significance of serum complements C3 and C4 in HCV-related chronic liver diseases and hepatocellular carcinoma. The Egyptian journal of immunology / Egyptian Association of Immunologists. ,vol. 12, pp. 91- ,(2005)
Mehmet Sait BUGDACI, Cetin KARACA, Canan ALKIM, Besir KESICI, Banu BAYRAKTAR, Mehmet SOKMEN, Serum complement C4 in chronic hepatitis C: correlation with histopathologic findings and disease activity. The Turkish journal of gastroenterology. ,vol. 23, pp. 33- 37 ,(2012) , 10.4318/TJG.2012.0310
Ming-Ling Chang, Chau-Ting Yeh, Deng-Yn Lin, Yu-Pin Ho, Chen-Ming Hsu, D Montgomery Bissell, Hepatic inflammation mediated by hepatitis C virus core protein is ameliorated by blocking complement activation BMC Medical Genomics. ,vol. 2, pp. 51- 51 ,(2009) , 10.1186/1755-8794-2-51
C. Dumestre-Perard, D. Ponard, C. Drouet, V. Leroy, J-P. Zarski, N. Dutertre, M. G. Colomb, Complement C4 monitoring in the follow‐up of chronic hepatitis C treatment Clinical and Experimental Immunology. ,vol. 127, pp. 131- 136 ,(2002) , 10.1046/J.1365-2249.2002.01729.X
Cotler, Wartelle, Larson, Gretch, Jensen, Carithers Jr, Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C. Journal of Viral Hepatitis. ,vol. 7, pp. 211- 217 ,(2000) , 10.1046/J.1365-2893.2000.00215.X
Daniel Lavanchy, The global burden of hepatitis C. Liver International. ,vol. 29, pp. 74- 81 ,(2009) , 10.1111/J.1478-3231.2008.01934.X
Sanaa M. Kamal, Imad A. Nasser, Hepatitis C genotype 4: What we know and what we don't yet know. Hepatology. ,vol. 47, pp. 1371- 1383 ,(2008) , 10.1002/HEP.22127
Kristina A. Stoermer, Thomas E. Morrison, Complement and viral pathogenesis Virology. ,vol. 411, pp. 362- 373 ,(2011) , 10.1016/J.VIROL.2010.12.045
Vito Racanelli, Barbara Rehermann, The liver as an immunological organ Hepatology. ,vol. 43, ,(2006) , 10.1002/HEP.21060